CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER
- 作者: Severova M1, Saginova E1, Gallyamov M2, Ermakov N3, Rodina A3,1, Fomin V1, Mukhin N1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University
- M.V. Lomonosov Moscow State University
- Research Institute of Medical Ecology
- 期: 卷 84, 编号 6 (2012)
- 页面: 15-20
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31029
- ID: 31029
如何引用文章
全文:
详细
作者简介
M Severova
I.M. Sechenov First Moscow State Medical University
Email: mseverova@mail.ru
Chair of Therapy and Occupational Medicine of Medicoprophylactic Department
E Saginova
I.M. Sechenov First Moscow State Medical UniversityChair of Therapy and Occupational Medicine of Medicoprophylactic Department
M Gallyamov
M.V. Lomonosov Moscow State UniversityChair of Internal Medicine of Fundamental Medicine Department
N Ermakov
Research Institute of Medical EcologyLaboratory of Development of Diagnostic Kits Moscow
A Rodina
Research Institute of Medical Ecology; I.M. Sechenov First Moscow State Medical UniversityChair of Biochemistry Moscow
V Fomin
I.M. Sechenov First Moscow State Medical University
Email: fomin_vic@mail.ru
Chair of Therapy and Occupational Medicine of Medicoprophylactic Department
N Mukhin
I.M. Sechenov First Moscow State Medical UniversityChair of Therapy and Occupational Medicine of Medicoprophylactic Department
参考
- Мухин Н. А., Моисеев В. С. Кардиоренальные соотношения и риск сердечно-сосудистых заболеваний. Вестн. РАМН 2003; 11: 50—55.
- Шестакова М. В., Ярек-Мартынова И. Р., Иванишина Н. С. и др. Кардиоренальный синдром при сахарном диабете 1-го типа: роль дисфункции эндотелия. Кардиология 2005; 6: 35—41.
- Ronco C., McCullough P., Anker S. D. et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur. Heart J. 2010; 31(6): 703—711
- Лазебник Л. Б., Звенигородская Л. А., Егорова Е. Г. Метаболический синдром у пациентов с заболеваниями органов пищеварения. Тер. арх. 2007; 79 (10): 9—13.
- Sowers J.R. The cardiomethabolic syndrome and liver disease. J. Cardiometab. Syndr. 2008; 3: 7—11
- Chang Y., Ryu S., Sung E. et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008; 57(4): 569-576.
- Goland S., Shimoni S., Zornitzki T. et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J. Clin. Gastroenterol. 2006; 40 (10): 949-955.
- Yasui K., Sumida Y., Mori Y. et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism 2011; 60 (5): 735—739.
- Комитет экспертов РМОАГ/ВНОК. Диагностика и лечение артериальной гипертензии. (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов). Систем. гипертензии 2010; 3: 5—26.
- Kidney Disease Outcome Quality Initiative. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 2002; 39 (Suppl. 2): S1— S246.
- Foppa M., Duncan B. B., Rohde L. E. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc. Ultrasound 2005; 3: 17.
- Чазова И. Е., Литвин А. Ю. Артериальная гипертония и синдром обструктивного апноэ во время сна. В кн:: Чазов Е. И., Чазова И. Е. Руководство по артериальной гипертонии. М.: Media Medica; 2005. 182—200.
- Огурцов П. П., Нужный В. П. Экспресс-диагностика (скрининг) хронической алкогольной интоксикации у больных соматического профиля. Клин. фармакол. и тер. 2001; 1: 34—39.
- Arase Y., Suzuki F., Kobayashi M. et al. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. Intern. Med. 2011; 50(10): 1081—1087.
- Kim H. C., Kim D. J., Huh K. B. Association between nonalcoholic fatty liver disease and carotid intima media — thickness according to the presence of metabolic syndrome. Atherosclerosis 2009; 204 (2): 521—525.
- Saarikoski L. A., Huupponen R. K., Viikari J. S. et al. Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults — the Cardiovascular Risk in Young Finns Study. Ann. Med. 2010; 42 (8): 603—611.
- Huang S. S., Huang P. H., Chen Y. H. et al. Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J. Atheroscler. Thromb. 2010; 17 (3): 295—303.
- Norata G. D., Raselli S., Grigore L. et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007; 38 (10): 2844—2846.
- Ma H., Gomez V., Lu L. et al. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2009; 24 (2): 233—237.